Back

Permanent pacemaker implantation after a new fully repositionable device for trans-catheter aortic valve implantation; impact on left ventricular function and myocardial deformation.

21 May 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Valvular heart disease (diagnosis, management and interventional therapies) Valvular heart disease HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Francisco Javier Irazusta Cordoba

Donostia University Hospital, San Sebastian (Spain)

9 More presentations in this session

Presentation thumbnail
The effects of TAVI on arterial stiffness and ventricular-arterial coupling
Doctor E. Sciatti (Bergamo, IT)
Abstract Slides
Presentation thumbnail
Mitral regurgitation severity correlates with symptoms and extent of left atrial dysfunction: effect of mitral valve repair
Doctor M. Lisi (Arezzo, IT)
Presentation thumbnail
Adverse events in operated and non-operated patients with severe aortic valve stenosis
Miss J. Bye (Oslo, NO)
Abstract Slides
Presentation thumbnail
Low cardiac output syndrome after aortic valve replacement in 2045 elderly patients
Professor W. Mistiaen (Antwerp, BE)
Abstract Slides
Presentation thumbnail
Magnesium orotate improves health-related quality of life after surgical valve replacement
Professor I. Gaisin (Izhevsk, RU)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Valvular heart disease (diagnosis, management and interventional therapies)

The Event

Event poster

HEART FAILURE 2016

21 May - 24 May 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources